QuidelOrtho Shares Drop on Carlyle's Secondary Offering

Dow Jones

2024-11-20

By Dean Seal

Shares of QuidelOrtho fell after the company said Carlyle Group was selling 8.26 million of its shares in an underwritten secondary offering.

The stock was down 7.3% at $35.75 in premarket trading on Wednesday. Shares had already fallen 48% year-to-date when the market closed Tuesday.

The maker of an at-home Covid-19 test and other products said after yesterday's closing bell that Carlyle Group would sell the shares in an offering set to close on Nov. 21. QuidelOrtho will not receive any proceeds from the offering.

Goldman Sachs is acting as the sole underwriter and will offer the shares to the public at a fixed price, the company said.

QuidelOrtho issued a press release on Tuesday night saying the offering had been priced, though it didn't provide the per-share price.

Write to Dean Seal at dean.seal@wsj.com

(END) Dow Jones Newswires

November 20, 2024 07:26 ET (12:26 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2484190510"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2484190510\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2484190510?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-20 20:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2484190510","market":"hk","top_or_hot":-1,"title":"QuidelOrtho Shares Drop on Carlyle's Secondary Offering","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n     By Dean Seal \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of QuidelOrtho fell after the company said Carlyle Group was selling 8.26 million of its shares in an underwritten secondary offering. \n</p>\n<p>\n  The stock was down 7.3% at $35.75 in premarket trading on Wednesday. Shares had already fallen 48% year-to-date when the market closed Tuesday. \n</p>\n<p>\n  The maker of an at-home Covid-19 test and other products said after yesterday's closing bell that Carlyle Group would sell the shares in an offering set to close on Nov. 21. QuidelOrtho will not receive any proceeds from the offering. \n</p>\n<p>\n  Goldman Sachs is acting as the sole underwriter and will offer the shares to the public at a fixed price, the company said. \n</p>\n<p>\n  QuidelOrtho issued a press release on Tuesday night saying the offering had been priced, though it didn't provide the per-share price. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Dean Seal at dean.seal@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 20, 2024 07:26 ET (12:26 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>QuidelOrtho Shares Drop on Carlyle's Secondary Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuidelOrtho Shares Drop on Carlyle's Secondary Offering\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2024-11-20 20:26</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n     By Dean Seal \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of QuidelOrtho fell after the company said Carlyle Group was selling 8.26 million of its shares in an underwritten secondary offering. \n</p>\n<p>\n  The stock was down 7.3% at $35.75 in premarket trading on Wednesday. Shares had already fallen 48% year-to-date when the market closed Tuesday. \n</p>\n<p>\n  The maker of an at-home Covid-19 test and other products said after yesterday's closing bell that Carlyle Group would sell the shares in an offering set to close on Nov. 21. QuidelOrtho will not receive any proceeds from the offering. \n</p>\n<p>\n  Goldman Sachs is acting as the sole underwriter and will offer the shares to the public at a fixed price, the company said. \n</p>\n<p>\n  QuidelOrtho issued a press release on Tuesday night saying the offering had been priced, though it didn't provide the per-share price. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Dean Seal at dean.seal@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 20, 2024 07:26 ET (12:26 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B64PRP62.GBP","symbol_name":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2484190510","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2484190510","pubTimestamp":1732105560,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of QuidelOrtho fell after the company said Carlyle Group was selling 8.26 million of its shares in an underwritten secondary offering.The stock was down 7.3% at $35.75 in premarket trading on Wednesday. Shares had already fallen 48% year-to-date when the market closed Tuesday.The maker of an at-home Covid-19 test and other products said after yesterday's closing bell that Carlyle Group would sell the shares in an offering set to close on Nov. 21. QuidelOrtho will not receive any proceeds from the offering.Goldman Sachs is acting as the sole underwriter and will offer the shares to the public at a fixed price, the company said.QuidelOrtho issued a press release on Tuesday night saying the offering had been priced, though it didn't provide the per-share price.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","QDEL":"窥得儿医药","BK4198":"医疗保健用品","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","BK4135":"资产管理与托管银行","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","BK4082":"医疗保健设备","CG":"凯雷"},"translate_title":"凯雷二次发行导致QuidelOrtho股价下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CG":0.9,"QDEL":0.9},"content_text":"By Dean Seal \n\n\n \n\n\n  Shares of QuidelOrtho fell after the company said Carlyle Group was selling 8.26 million of its shares in an underwritten secondary offering. \n\n\n  The stock was down 7.3% at $35.75 in premarket trading on Wednesday. Shares had already fallen 48% year-to-date when the market closed Tuesday. \n\n\n  The maker of an at-home Covid-19 test and other products said after yesterday's closing bell that Carlyle Group would sell the shares in an offering set to close on Nov. 21. QuidelOrtho will not receive any proceeds from the offering. \n\n\n  Goldman Sachs is acting as the sole underwriter and will offer the shares to the public at a fixed price, the company said. \n\n\n  QuidelOrtho issued a press release on Tuesday night saying the offering had been priced, though it didn't provide the per-share price. \n\n\n \n\n\n  Write to Dean Seal at dean.seal@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 20, 2024 07:26 ET (12:26 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}